PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Third Quarter 2021 Results
- Third quarter total net revenue of
$11.3 million , up 52% from Q3, 2020 - Third quarter net wholesale and direct-to-consumer sales up over 100% from Q3, 2020
- Third quarter licensing revenue up 31% from Q3, 2020
Third Quarter 2021 Financial Results
Total revenue was
Net loss attributable to
Nine Month 2021 Financial Results
Total revenue was
Net loss attributable to
Balance Sheet
The Company's balance sheet at
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Condensed Consolidated Balance Sheets | |||||||
(in thousands, except share and per share data) | |||||||
(Unaudited) | |||||||
Assets | |||||||
Current Assets: | |||||||
Cash and cash equivalents | $ | 3,981 | $ | 4,957 | |||
Accounts receivable, net | 10,949 | 8,889 | |||||
Inventory | 3,430 | 1,216 | |||||
Prepaid expenses and other current assets | 1,711 | 1,085 | |||||
Total current assets | 20,071 | 16,147 | |||||
Non-Current Assets: | |||||||
Property and equipment, net | 3,481 | 3,367 | |||||
Operating lease right-of-use assets | 6,831 | 8,668 | |||||
Trademarks and other intangibles, net | 99,859 | 93,535 | |||||
Restricted cash | 739 | 1,109 | |||||
Other assets | 222 | 228 | |||||
Total non-current assets | 111,132 | 106,907 | |||||
Total Assets | $ | 131,203 | $ | 123,054 | |||
Liabilities and Equity | |||||||
Current Liabilities: | |||||||
Accounts payable, accrued expenses and other current liabilities | $ | 5,444 | $ | 4,442 | |||
Accrued payroll | 683 | 973 | |||||
Accrued consideration payable | - | - | |||||
Current portion of operating lease obligations | 1,315 | 2,101 | |||||
Current portion of long-term debt | 4,998 | 2,800 | |||||
Total current liabilities | 12,440 | 10,316 | |||||
Long-Term Liabilities: | |||||||
Long-term portion of operating lease obligations | 7,295 | 8,469 | |||||
Long-term debt, less current portion | 20,233 | 13,838 | |||||
Contingent obligations | 7,539 | 900 | |||||
Deferred tax liabilities, net | 1,038 | 3,052 | |||||
Other long-term liabilities | 591 | 224 | |||||
Total long-term liabilities | 36,696 | 26,483 | |||||
Total Liabilities | 49,136 | 36,799 | |||||
Commitments and Contingencies | |||||||
Equity: | |||||||
Preferred stock, |
- | - | |||||
Common stock, |
20 | 19 | |||||
Paid-in capital | 102,936 | 102,324 | |||||
Accumulated deficit | (21,836 | ) | (16,595 | ) | |||
Total Xcel Brands, Inc. stockholders' equity | 81,120 | 85,748 | |||||
Noncontrolling interest | 947 | 507 | |||||
Total Equity | 82,067 | 86,255 | |||||
Total Liabilities and Equity | $ | 131,203 | $ | 123,054 | |||
Unaudited Condensed Consolidated Statements of Operations | |||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Revenues | |||||||||||||||
Net licensing revenue | $ | 6,854 | $ | 5,236 | $ | 17,385 | $ | 15,378 | |||||||
Net sales | 4,407 | 2,155 | 12,449 | 6,590 | |||||||||||
Net revenue | 11,261 | 7,391 | 29,834 | 21,968 | |||||||||||
Cost of goods sold (sales) | 2,865 | 1,270 | 7,763 | 3,923 | |||||||||||
Gross profit | 8,396 | 6,121 | 22,071 | 18,045 | |||||||||||
Operating costs and expenses | |||||||||||||||
Salaries, benefits and employment taxes | 4,185 | 2,968 | 12,286 | 9,798 | |||||||||||
Other selling, general and administrative expenses | 3,463 | 2,159 | 9,591 | 7,153 | |||||||||||
Stock-based compensation | 163 | 49 | 754 | 780 | |||||||||||
Depreciation and amortization | 1,891 | 1,437 | 4,949 | 4,069 | |||||||||||
Government assistance - Paycheck Protection Program | - | (176 | ) | - | (1,816 | ) | |||||||||
Asset impairment charges | - | 31 | 0 | 113 | |||||||||||
Total operating costs and expenses | 9,702 | 6,468 | 27,580 | 20,097 | |||||||||||
Other income | - | 46 | - | 46 | |||||||||||
Operating loss | (1,306 | ) | (301 | ) | (5,509 | ) | (2,006 | ) | |||||||
Interest and finance expense | |||||||||||||||
Interest expense - term loan debt | 565 | 303 | 1363 | 926 | |||||||||||
Other interest and finance charges (income), net | 23 | 1 | 127 | (29 | ) | ||||||||||
Loss on extinguishment of debt | - | - | 821 | - | |||||||||||
Total interest and finance expense | 588 | 304 | 2,311 | 897 | |||||||||||
Loss before income taxes | (1,894 | ) | (605 | ) | (7,820 | ) | (2,903 | ) | |||||||
Income tax benefit | (535 | ) | (145 | ) | (2,019 | ) | (269 | ) | |||||||
Net loss | (1,359 | ) | (460 | ) | (5,801 | ) | (2,634 | ) | |||||||
Less: Net loss attributable to noncontrolling interest | (223 | ) | (26 | ) | (560 | ) | (95 | ) | |||||||
Net loss attributable to |
$ | (1,136 | ) | $ | (434 | ) | $ | (5,241 | ) | $ | (2,539 | ) | |||
Loss per share attributed to |
|||||||||||||||
Basic and diluted net loss per share | $ | (0.06 | ) | $ | (0.02 | ) | $ | (0.27 | ) | $ | (0.13 | ) | |||
Weighted average number of common shares outstanding: | |||||||||||||||
Basic and diluted weighted average common shares outstanding | 19,541,774 | 19,231,040 | 19,418,469 | 19,078,453 | |||||||||||
Unaudited Condensed Consolidated Statements of Cash Flows | |||||||
(in thousands) | |||||||
For the Nine Months Ended | |||||||
2021 | 2020 | ||||||
Cash flows from operating activities | |||||||
Net loss | $ | (5,801 | ) | $ | (2,634 | ) | |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||
Depreciation and amortization expense | 4,949 | 4,069 | |||||
Asset impairment charges | - | 113 | |||||
Amortization of deferred finance costs included in interest expense | 211 | 72 | |||||
Stock-based compensation | 754 | 780 | |||||
Provision for doubtful accounts | 132 | 1,054 | |||||
Loss on extinguishment of debt (non-cash portion) | 454 | - | |||||
Deferred income tax benefit | (2,019 | ) | (269 | ) | |||
- | (46 | ) | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (2,192 | ) | 1,380 | ||||
Inventory | (2,214 | ) | 176 | ||||
Prepaid expenses and other assets | (620 | ) | 187 | ||||
Accounts payable, accrued expenses and other current liabilities | 572 | (2,403 | ) | ||||
Cash paid in excess of rent expense | (122 | ) | (276 | ) | |||
Other liabilities | 367 | - | |||||
Net cash (used in) provided by operating activities | (5,529 | ) | 2,203 | ||||
Cash flows from investing activities | |||||||
Cash consideration for acquisition of Lori Goldstein assets | (3,661 | ) | - | ||||
Net proceeds from sale of assets | 46 | ||||||
Purchase of other intangible assets | (39 | ) | - | ||||
Purchase of property and equipment | (1,049 | ) | (700 | ) | |||
Net cash used in investing activities | (4,749 | ) | (654 | ) | |||
Cash flows from financing activities | |||||||
Proceeds from exercise of stock options | 5 | - | |||||
Shares repurchased including vested restricted stock in exchange for withholding taxes | - | (187 | ) | ||||
Cash contribution from non-controlling interest | 1,000 | 300 | |||||
Proceeds from revolving loan debt | 2,498 | - | |||||
Proceeds from long-term debt | 25,000 | (20 | ) | ||||
Payment of deferred finance costs | (1,204 | ) | - | ||||
Payment of long-term debt | (18,000 | ) | (1,500 | ) | |||
Payment of breakage fees associated with extinguishment of long-term debt | (367 | ) | - | ||||
Net cash provided by (used in) financing activities | 8,932 | (1,407 | ) | ||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | (1,346 | ) | 142 | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 6,066 | 5,750 | |||||
Cash, cash equivalents, and restricted cash at end of period | $ | 4,720 | $ | 5,892 | |||
Reconciliation to amounts on consolidated balance sheets: | |||||||
Cash and cash equivalents | 3,981 | $ | 4,783 | ||||
Restricted cash | 739 | 1,109 | |||||
Total cash, cash equivalents, and restricted cash | $ | 4,720 | $ | 5,892 | |||
Supplemental disclosure of non-cash activities: | |||||||
Operating lease right-of-use asset | $ | (722 | ) | $ | 797 | ||
Operating lease obligation | $ | (722 | ) | $ | 797 | ||
Contingent obligation related to acquisition of Lori Goldstein assets at fair value | $ | 6,639 | $ | - | |||
Liability for equity-based bonuses | $ | 140 | $ | 93 | |||
Supplemental disclosure of cash flow information: | |||||||
Cash paid during the period for income taxes | $ | 18 | $ | 58 | |||
Cash paid during the period for interest | $ | 1,346 | $ | 1,092 | |||
Three Months Ended | Nine Months Ended | ||||||||||||||
($ in thousands) | |||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (1,136 | ) | (434 | ) | $ | (5,241 | ) | (2,539 | ) | |||||
Amortization of trademarks | 1,519 | 1,107 | 3,915 | 3,323 | |||||||||||
Stock-based compensation | 163 | 49 | 754 | 780 | |||||||||||
Loss on extinguishment of debt | - | - | 821 | - | |||||||||||
(Recovery of) costs in connection with potential acquisition | - | (189 | ) | - | (210 | ) | |||||||||
Certain adjustments to provision for doubtful accounts | - | 385 | 132 | 971 | |||||||||||
Property and equipment impairment | - | 31 | - | 113 | |||||||||||
Gain on the sale of assets | (46 | ) | (46 | ) | |||||||||||
Deferred income tax (benefit) provision | (535 | ) | (145 | ) | (2,019 | ) | (269 | ) | |||||||
Non-GAAP net (loss) income | $ | 11 | $ | 758 | $ | (1,638 | ) | $ | 2,123 | ||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Diluted loss per share | $ | (0.06 | ) | $ | (0.02 | ) | $ | (0.27 | ) | $ | (0.13 | ) | |||
Amortization of trademarks | 0.08 | 0.06 | 0.20 | 0.16 | |||||||||||
Stock-based compensation | 0.01 | - | 0.04 | 0.04 | |||||||||||
Loss on extinguishment of debt | - | - | 0.04 | - | |||||||||||
(Recovery of) costs in connection with potential acquisition | - | (0.01 | ) | - | (0.01 | ) | |||||||||
Certain adjustments to provision for doubtful accounts | - | 0.02 | 0.01 | 0.05 | |||||||||||
Property and equipment impairment | - | - | - | 0.02 | |||||||||||
Deferred income tax (benefit) provision | (0.03 | ) | (0.01 | ) | (0.10 | ) | (0.01 | ) | |||||||
Non-GAAP diluted EPS | $ | - | $ | 0.04 | $ | (0.08 | ) | $ | 0.12 | ||||||
Non-GAAP weighted average diluted shares | 20,323,358 | 19,291,275 | 19,418,469 | 19,092,828 | |||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
($ in thousands) | |||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (1,136 | ) | $ | (434 | ) | $ | (5,241 | ) | $ | (2,539 | ) | |||
Depreciation and amortization | 1,891 | 1,437 | 4,949 | 4,069 | |||||||||||
Interest and finance expense | 588 | 304 | 2,311 | 897 | |||||||||||
Income tax (benefit) provision | (535 | ) | (145 | ) | (2,019 | ) | (269 | ) | |||||||
State and local franchise taxes | 33 | 41 | 105 | 124 | |||||||||||
Stock-based compensation | 163 | 49 | 754 | 780 | |||||||||||
(Recovery of) costs in connection with potential acquisition | - | (189 | ) | - | (210 | ) | |||||||||
Certain adjustments to provision for doubtful accounts | - | 385 | 132 | 971 | |||||||||||
Gain on the sale of assets | - | (46 | ) | - | (46 | ) | |||||||||
Property and equipment impairment | - | 31 | - | 113 | |||||||||||
Adjusted EBITDA | $ | 1,004 | $ | 1,433 | $ | 991 | $ | 3,890 | |||||||
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results. We incurred certain costs in the prior year which we could have eliminated but elected not to do so in light of government assistance received through the Paycheck Protection Program under the CARES Act (the “PPP Benefit”), which represents a cash benefit directly related to the Company’s operating expenses incurred. Accordingly, the PPP Benefit is not considered a reconciling item for purposes of the computation of non-GAAP net income and Adjusted EBITDA for the prior year periods.
Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under our term loan debt agreement. Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
Source: Xcel Brands, Inc